- Filed
- Aug 6, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2021 · Jun 30, 2021 | 401.45K sh |
| Shares Diluted | Q2 2021 · Jun 30, 2021 | 399.55K sh |
| Shares Diluted | Q2 2021 · Jun 30, 2020 | 291.99K sh |
| Shares Diluted | Q2 2021 · Jun 30, 2020 | 238.1K sh |
| Stock Repurchased | Q2 2021 · Jun 30, 2021 | $9.9M |
| Stock Repurchased | Q2 2021 · Jun 30, 2020 | $0 |
| Capex | Q2 2021 · Jun 30, 2021 | $6.22M |
| Capex | Q2 2021 · Jun 30, 2020 | $3.34M |
| Operating Cash Flow | Q2 2021 · Jun 30, 2021 | −$176.38M |
| Operating Cash Flow | Q2 2021 · Mar 31, 2021 | −$59.74M |
| Operating Cash Flow | Q2 2021 · Dec 31, 2020 | −$194.16M |
| Operating Cash Flow | Q2 2021 · Sep 30, 2020 | −$127.86M |
| Operating Cash Flow restated | Q2 2021 · Jun 30, 2020 | −$146.98M |
| Cash And Equivalents | Q2 2021 · Jun 30, 2021 | $2.65B |
| Cash And Equivalents | Q2 2021 · Dec 31, 2020 | $1.82B |
| Cash And Equivalents | Q2 2021 · Jun 30, 2020 | $1.24B |
| Stockholders Equity | Q2 2021 · Jun 30, 2021 | $2.21B |
| Stockholders Equity | Q2 2021 · Mar 31, 2021 | $2.32B |
| Stockholders Equity | Q2 2021 · Dec 31, 2020 | $2.63B |
| Stockholders Equity restated | Q2 2021 · Jun 30, 2020 | $2.14B |
| Stockholders Equity | Q2 2021 · Mar 31, 2020 | −$101.95M |
| Stockholders Equity | Q2 2021 · Dec 31, 2019 | −$49.58M |
| Current Liabilities | Q2 2021 · Jun 30, 2021 | $647.03M |
| Current Liabilities | Q2 2021 · Dec 31, 2020 | $554.41M |
| Total Liabilities | Q2 2021 · Jun 30, 2021 | $2.15B |
| Total Liabilities | Q2 2021 · Dec 31, 2020 | $807.98M |
| Current Assets | Q2 2021 · Jun 30, 2021 | $3.06B |
| Current Assets | Q2 2021 · Dec 31, 2020 | $2.19B |
| Total Assets | Q2 2021 · Jun 30, 2021 | $4.36B |
| Total Assets | Q2 2021 · Dec 31, 2020 | $3.44B |
| Eps Diluted | Q2 2021 · Jun 30, 2021 | −$0.76 |
| Eps Diluted | Q2 2021 · Jun 30, 2021 | −$1.63 |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | −$1.80 |
| Eps Diluted | Q2 2021 · Jun 30, 2020 | −$2.49 |
| Eps Basic | Q2 2021 · Jun 30, 2021 | −$0.76 |
| Eps Basic | Q2 2021 · Jun 30, 2021 | −$1.63 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | −$1.80 |
| Eps Basic | Q2 2021 · Jun 30, 2020 | −$2.49 |
| Sga Expense | Q2 2021 · Jun 30, 2021 | $198.81M |
| Sga Expense | Q2 2021 · Jun 30, 2021 | $367.8M |
| Sga Expense | Q2 2021 · Jun 30, 2020 | $107.31M |
| Sga Expense | Q2 2021 · Jun 30, 2020 | $146.8M |
| Net Income | Q2 2021 · Jun 30, 2021 | −$305.53M |
| Net Income | Q2 2021 · Jun 30, 2021 | −$651.87M |
| Net Income | Q2 2021 · Mar 31, 2021 | −$346.34M |
| Net Income restated | Q2 2021 · Jun 30, 2020 | −$524.8M |
| Net Income restated | Q2 2021 · Jun 30, 2020 | −$593.48M |
| Net Income | Q2 2021 · Mar 31, 2020 | −$68.68M |
| Operating Income | Q2 2021 · Jun 30, 2021 | −$321.55M |
| Operating Income | Q2 2021 · Jun 30, 2021 | −$646.35M |
| Operating Income | Q2 2021 · Jun 30, 2020 | −$160.44M |
| Operating Income | Q2 2021 · Jun 30, 2020 | −$226.56M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2021 | $187.01M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2021 | $370.23M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2020 | $47.33M |
| Cost Of Revenue | Q2 2021 · Jun 30, 2020 | $90.75M |